Inflammatory bowel disease in underserved populations: lessons for practice

Curr Opin Gastroenterol. 2022 Jul 1;38(4):321-327.doi: 10.1097/MOG.0000000000000855.


Florence-Damilola Odufalu 1Aiya Aboubakr 2Adjoa Anyane-Yeboa 3


Author information

1Division of GI & Liver Disease, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.

2Department of Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, New York.

3Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Abstract


Purpose of review: The incidence of inflammatory bowel disease (IBD) is increasing in minority groups across the USA. There are racial and ethnic disparities in IBD care and outcomes that are rooted in historical injustice and inequities in the social determinants of health.

Recent findings: Current literature has identified racial, ethnic and sociodemographic disparities in therapeutics and outcomes for IBD, including disease severity, morbidity and mortality.

Summary: Strategies to achieve equity in IBD include tackling structural racism as a driver of health disparities and making actionable changes against multilevel barriers to care.


© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.